ROSIA-PCP
ROSIA-PCP is an EU Horizon 2020-funded Pre-Commercial Procurement project that develops an open telerehabilitation platform for patients in rural Europe. Coordinated by Spain's IACS and procured jointly by public health systems in Spain, Portugal, and Ireland.
- Company typePrivate
- Founded2021
- HeadquartersZaragoza, Spain
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What ROSIA-PCP does
ROSIA-PCP is a Pre-Commercial Procurement (PCP) initiative coordinated by the Instituto Aragonés de Ciencias de la Salud (IACS), a public research entity under the Aragon Health Department in Zaragoza, Spain. Funded by the European Commission's Horizon 2020 programme under grant agreement No 101017606, the project runs for 54 months (January 2021 through December 2025) with a €5 million budget, of which €3.9 million is allocated to a competitive three-phase R&D tender (Solution Design, Prototype Development, Field Testing). Its buyer group consists of three public healthcare procurers—Servicio Aragonés de Salud (Spain), Unidade Local de Saúde de Coimbra (Portugal), and the National Rehabilitation Hospital (Ireland)—who jointly steer the development of an open telerehabilitation platform for patients in rural and isolated parts of Europe. The 12-partner consortium spans five countries and includes research centres (Eurecat, CERTH/ITI, IGTP, IPN, IFIC), consultancies (VALDE Innova, The Decision Group, IEXP, PPCN), two Portuguese municipalities (Penela, Soure), and a facilitation partner (Eoh-for-Good).
The platform architecture is centred on an open integration layer that combines a service and device catalogue, SDK/APIs for third-party developers, a governance and quality-management system, and a shared care-plan interface for clinicians and patients. Functional components include patient self-management apps, AI-driven recommender systems across the four health pillars, decision support for risk stratification, VR/AR-enabled immersive rehabilitation, inertial-sensor-based monitoring, and a shared care plan with patient management for healthcare teams. Two Phase 3 solutions are being field-tested: REHABILIFY (led by Fundació Eurecat with Doole Health and IGTP) and RAISE (led by CERTH with TELEVES, IBV, Vidavo, University of Ioannina, and INESCTEC), covering seven pathologies—chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardiovascular disease, hip fracture, and COVID-19—with over 100 patients piloted across rural Aragón, Coimbra, and Dublin.
The business model is public R&D procurement rather than commercial sales: ROSIA-PCP does not sell the platform; the three procurers act as anchor demand-side participants, and suppliers are selected through open competition. Marketing and stakeholder engagement span the project website, LinkedIn, X, Facebook, YouTube, newsletters, Open Market Consultation events, an online matchmaking platform, co-creation sessions, and a December 2025 end-of-project policy workshop with European Commission representation. Strategic positioning post-2025 depends on commercial uptake of the open platform by additional European public healthcare systems—a step that would be enabled by the certification, evidence, and policy outputs of the project but is not yet contracted.
ROSIA-PCP firmographics
Firmographics- Name
- ROSIA-PCP
- Legal name
- Instituto Aragonés de Ciencias de la Salud (IACS)
- Website
- https://rosia-pcp.eu
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- ROSIA-PCP is an EU Horizon 2020-funded Pre-Commercial Procurement project that develops an open telerehabilitation platform for patients in rural Europe. Coordinated by Spain's IACS and procured jointly by public health systems in Spain, Portugal, and Ireland.
- Ownership category
- akta.pro rank
ROSIA-PCP industry classification
Industry- Product category
- Telerehabilitation Software Platform
- NAICS
- Home Health Care Services (62161), Computer Systems Design and Related Services (5415), Scientific Research and Development Services (5417)
- SIC
- Services-Home Health Care Services (8082), Services-Computer Integrated Systems Design (7373), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Decentralized & Hybrid Trial Site Services (Home Health/Nursing) (HLAGACAH)
Keywords
Where ROSIA-PCP is headquartered
LocationHeadquarters
- HQ city
- Zaragoza
- HQ country
- Spain
- HQ region
- Europe
Offices3 records
Markets served
ROSIA-PCP business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Distribution channels1 record
Marketing channels11 records
ROSIA-PCP product offering
Product offeringCore offering
ROSIA-PCP is a Pre-Commercial Procurement (PCP) project that designs, procures, and field-tests an open telerehabilitation platform for patients in rural and isolated areas of Europe. It jointly procures R&D services from technology providers across three European public healthcare systems (Spain, Portugal, Ireland) through a three-phase competitive process, ultimately delivering an open platform with a catalogue of integrated rehabilitation apps, services, and devices that supports patient self-management and clinical remote monitoring.
Product overview
ROSIA-PCP is a Pre-Commercial Procurement (PCP) initiative developing an open innovation platform for telerehabilitation in remote rural areas. The offering is structured as a platform-plus-modules architecture centered on the ROSIA Open Platform, which integrates third-party solutions through an app and service catalogue. Two main Phase 3 solutions (REHABILIFY and RAISE) are being field-tested alongside legacy Phase 1/2 solutions (PROHAB, ULTREIA, RehabilityOpen, REHABILITA+). The ecosystem includes patient self-management tools, AI-powered recommender systems, decision support for clinicians, and SDK/APIs for developers to build and integrate rehabilitation applications. Seven pathologies are targeted: chronic spinal cord injury, acquired brain injury, COPD, arthroplasty, cardio-vascular disease, hip fracture, and COVID-19.
Differentiator
Problem solved
Functional benefit
Brands
- Rehabilify: Telerehabilitation solution developed by a Spanish Consortium led by Fundació Eurecat, involving Doole Health and Germans Trias i Pujol research centre (IGTP)
- RAISE
Products and services
- ROSIA Open Platform The main ROSIA open telerehabilitation platform designed to integrate third-party solutions, devices, and apps into a catalogue for clinical prescription by healthcare professionals. It enables healthcare systems to deploy hybrid telerehabilitation services within integrated care pathways across rural and remote patient populations.
- REHABILIFY (evolved from PROHAB) Phase 3 telerehabilitation solution developed by a Spanish consortium led by Fundació Eurecat, including Doole Health and Germans Trias i Pujol research centre (IGTP). Provides an open platform with a Patient Management System, AI recommender services, and SDK/APIs that enable third-party integration of rehabilitation technology.
- RAISE Phase 3 telerehabilitation solution developed by an international consortium led by CERTH (Centre for Research and Technology Hellas), integrating TELEVES, IBV, Vidavo, the University of Ioannina, and INESCTEC. Features VR, AR, and AI tools for clinical tele-rehabilitation, a catalogue of devices and services for self-management, and a developer layer for third-party integration.
- ULTREIA Phase 1 telerehabilitation solution developed by Bahia Software and Rehametric, providing an open ICT infrastructure for telerehabilitation technologies and a catalogue of telerehabilitation technologies with a development platform.
- RehabilityOpen Phase 1 telerehabilitation solution developed by the FORTH consortium, featuring a digital platform for personalised therapy design, remote patient monitoring, and secure telemonitoring channels with GDPR-compliant data handling.
- REHABILITA+ Phase 1/2 telerehabilitation solution developed by GMV, featuring an Open Platform for coordinating care teams, shared care plans, personalised therapy plans, and patient self-management with mental health, nutrition, and monitoring services.
Quantifiable outcome
- Over 100 patients across Spain, Portugal, and Ireland tested the ROSIA solutions during the pilot phase, covering 7 pathologies including spinal cord injury, brain injury, COPD, arthroplasty, cardiovascular disease, hip fracture, and COVID-19.
- +2 more outcomes
Companies that use ROSIA-PCP
Customer profileNamed customers3 records
Segments4 records
Ideal customer profiles2 records
ROSIA-PCP technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability8 records
Feature5 records
ROSIA-PCP partnerships and signals
Strategic signalPartnerships
19 partnerships are on record, tiered core and supporting.
- IACS (Instituto Aragonés de Ciencias de la Salud)coreIACS is the main coordinator of the ROSIA project. Created in 2002, it is an independent public entity under the Aragon Health Department. Its mission is to promote research, innovation, and knowledge brokering in biomedicine and health sciences. IACS coordinates the joint procurement on behalf of the buyers group and holds responsibilities including Evidence Based Decision Making (EBDM), HTA agency functions, and support for biomedical research through its Project Office and 10 Research Core Facilities. Located at the Aragon Biomedical Research Centre (CIBA) in Zaragoza.
- SALUD (Servicio Aragonés de Salud)coreSALUD is the public health provider for Aragón, Spain, with responsibilities for overall management and coordination of healthcare resources. It has 12 General Hospitals, 110 Primary Health Centres, and 5 Geriatric hospitals. It is one of the three public procurers and part of the buyers group. SALUD is a four-star reference site from the EIP on AHA (Active and Healthy Ageing), recognising its commitment to innovation for active and healthy ageing.
- NRH (National Rehabilitation Hospital)coreNRH is Ireland's only hospital providing comprehensive specialist neuro-rehabilitation for patients following acquired brain injury, spinal cord injury, or amputation. Founded in 1961, it has 485 staff (FTE), annual turnover of approximately €41 million, and is accredited by CARF. It serves as a national provider of rehabilitation in Ireland and a procuring partner in the ROSIA project.
- ULS Coimbra (Unidade Local de Saúde de Coimbra)coreThe Coimbra Healthcare Integrated Delivery System unifies public health, primary care, and specialised services in Portugal with over 11,000 employees. It exemplifies integrated care and innovation, combining rehabilitation and palliative care with a seamless patient journey. The system collaborates with academic and research institutions and is a benchmark for integrated care in Portugal.
- VALDE InnovasupportingVALDE is a Spanish consulting company with a network of senior collaborators specialised in innovation procurement (PPI and PCP) at European and national level. Since 2012, VALDE has developed expertise in ICT for Active and Healthy Aging and acts as procurement coordinator in the ROSIA project, providing expertise in European project management, co-creation methodologies, business development, and strategic procurement.
- Instituto Pedro Nunes (IPN)supportingIPN is a non-profit private organisation created in 1991 from the University of Coimbra. It promotes innovation through research and technological development, business incubation, and specialised training. IPN leads co-creation and co-design with end-users in ROSIA and is co-founder of the Ageing@Coimbra reference site of the EIP on AHA.
- IFIC (International Foundation for Integrated Care)supportingIFIC is a not-for-profit network incorporated in the Netherlands that brings together academics, researchers, managers, practitioners, and policymakers to advance integrated care. IFIC leads the design of the telerehabilitation model in ROSIA and acts as a research and knowledge exchange hub.
- The Decision GroupsupportingThe Decision Group is a Dutch consultancy firm pioneering in Value-Based Healthcare since 2006. Led by Prof. Dr. Fred van Eenennaam, the team provides methodology based on Porter, Teisberg, and Kaplan's VBHC principles. In ROSIA, they are responsible for the Evaluation Framework.
- IEXP (Instituto para la Experiencia del Paciente)supportingIEXP is the first organisation in Spain dedicated specifically to patient experience and one of Europe's reference organisations. All IEXP professionals come from the health or pharmaceutical field. IEXP engages patients in the solution co-creation process within ROSIA, focusing on ensuring technology produces real changes in patients' lives using PROMs and PREMs.
- PPCN.xyz ApssupportingPPCN is a health and care tech consultancy based in Copenhagen and Bangkok. It is responsible for the ICT functional specification in ROSIA and has vast experience in the healthy ageing tech market, with involvement in AI-based ageing tech, telehealth, HIS systems, and advanced medical device remote patient monitoring projects since 2007.
- Municipality of PenelasupportingPenela is a small municipality of about 135 km² in the Central Region of Portugal. It joined the European Network of Living Labs (ENoLL) in 2010 through the Smart Rural Living Lab project. In ROSIA, Penela supports piloting activities in its rural community.
- Municipality of SouresupportingSoure is a municipality of about 260 km² in the Central Region of Portugal near Coimbra, with around 20,000 inhabitants. It is involved as a pilot partner in ROSIA, supporting the testing of telerehabilitation solutions in its rural community settings.
- Fundació Eurecat (Rehabilify solution)coreFundació Eurecat is a Spanish technology centre leading the Rehabilify solution in ROSIA Phase 3. The consortium also includes Doole Health (SME) and Germans Trias i Pujol research centre (IGTP). The solution proposes implementation of the ROSIA Open Platform with Patient Management System, AI services, and developer tools for rehabilitation technology integration.
- CERTH (Centre for Research and Technology Hellas / Ethniko Kentro - RAISE solution)coreCERTH is a Greek research centre leading the RAISE solution in ROSIA Phase 3. The international consortium also integrates Spanish entities TELEVES, IBV, and Vidavo; Greek Research Committee University Ioannina (UoI); and Portuguese INESCTEC. RAISE proposes an open platform with VR, AR, and AI for telerehabilitation self-management.
- 2CARE4EU (PCP Group)supportingROSIA is part of 2CARE4EU, a group of PCPs aiming to develop innovative healthcare ICT-based solutions for chronic disease treatment, remote rehabilitation, predictive analysis for frailty prevention, and integrated care for multimorbidity. The group has benefited from Horizon Results Booster support.
- CareMatrixsupportingCareMatrix is another PCP project in the 2CARE4EU group with which ROSIA collaborates on developing innovative healthcare solutions.
- eCare PCPsupportingeCare is another PCP project in the 2CARE4EU group collaborating with ROSIA on healthcare ICT solutions for integrated care.
- InCareHeartsupportingInCareHeart is another PCP project in the 2CARE4EU group collaborating with ROSIA on cardiovascular care and integrated solutions.
- Eoh-for-GoodsupportingEoh-for-Good facilitated the four co-creation sessions held in 2025 with ROSIA stakeholders (healthcare professionals, patients, developers, and procurers) to gather feedback on the telerehabilitation solutions.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
ROSIA-PCP competitors and assessment
Company assessmentDirect peers
- Physitrack: Telehealth platform for physical therapists providing remote patient monitoring, exercise prescription, and outcome tracking — directly comparable to ROSIA's remote rehabilitation service catalogue and clinician-facing tools.
- Sword Health: Digital MSK and rehabilitation platform combining AI-enabled virtual therapists and clinician oversight; directly comparable to ROSIA's home-based telerehabilitation and AI recommender approach across MSK and post-surgical indications.
- Hinge Health: Digital musculoskeletal care platform offering at-home exercise therapy, wearable sensors, and clinician coaching — closely comparable to ROSIA's home-care pathways, gamified exercise catalogue, and patient self-management focus.
- Kaia Health: Digital therapeutic for MSK and COPD rehabilitation delivered via app with AI-driven motion analysis; comparable to ROSIA's AI recommender systems and COPD use case among its seven piloted pathologies.
Broad incumbents
- Tunstall Healthcare: Established UK-based provider of telecare and remote monitoring solutions for public health and social care; relevant as a scaled incumbent in the broader European home-care technology market ROSIA targets.
- KRY (Livi): Largest European digital primary care provider operating across multiple EU geographies; broad incumbent in telehealth whose scale and country coverage map to ROSIA's cross-border public healthcare procurement model.
- Omada Health: Digital care platform for chronic conditions (cardiovascular, diabetes, MSK) combining coaching, wearable data, and clinician support — comparable to ROSIA's integrated care pathways and risk-stratification AI for cardiovascular rehabilitation.
Others
- EIT Health: European health innovation accelerator/network under EIT; comparable as an adjacent enabling ecosystem that connects SMEs and procurement programmes (similar to ROSIA's matchmaking and OMC mechanisms) into European public healthcare.
Emerging players
- NeuroNation: Digital cognitive training and brain-health platform; partially comparable to ROSIA's acquired brain injury rehabilitation use case and its gamification/AI personalisation capabilities.
- Doccla: European virtual ward and remote patient monitoring provider working with NHS and EU public systems; comparable to ROSIA's home-monitoring and shared-care-plan components in a commercial public-sector deployment context.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights5 records
Customer concentration
ROSIA-PCP social profiles
Digital presenceROSIA-PCP financial estimates
Financial estimateRevenue estimate
Valuation estimate
ROSIA-PCP leadership team
Management profileNumber of profiles
ROSIA-PCP funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
ROSIA-PCP M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about ROSIA-PCP
What does ROSIA-PCP do?
ROSIA-PCP is a Pre-Commercial Procurement (PCP) project that designs, procures, and field-tests an open telerehabilitation platform for patients in rural and isolated areas of Europe. It jointly procures R&D services from technology providers across three European public healthcare systems (Spain, Portugal, Ireland) through a three-phase competitive process, ultimately delivering an open platform with a catalogue of integrated rehabilitation apps, services, and devices that supports patient self-management and clinical remote monitoring.
Is ROSIA-PCP a public or private company?
ROSIA-PCP is a private company. It is classified as unknown and is currently operating.
When was ROSIA-PCP founded?
ROSIA-PCP was founded in 2021. It employs 11 to 50 people.
Where is ROSIA-PCP based?
ROSIA-PCP is headquartered in Zaragoza, Spain, in the Europe region.
Who are ROSIA-PCP's main competitors?
Direct peers on record are Physitrack, Sword Health, Hinge Health and Kaia Health. Broad incumbents are Tunstall Healthcare, KRY (Livi) and Omada Health. EIT Health is listed as an others. Emerging players are NeuroNation and Doccla.
Does ROSIA-PCP have an API?
No public API is recorded for ROSIA-PCP.
What industry is ROSIA-PCP in?
ROSIA-PCP's product category is Telerehabilitation Software Platform. Its primary akta.pro industry code is HLAGACAH, Decentralized & Hybrid Trial Site Services (Home Health/Nursing). Its NAICS code is 62161 and its SIC code is 8082.